Insider trading
Officers, directors, and 10% owners buying and selling their own company's stock, from SEC Form 4 filings. Newest first.
Showing the last 10 days.Sign up free for 90 days
| Type | Symbol | Insider | Shares | Price | Value | Traded | Filed |
|---|---|---|---|---|---|---|---|
| Sell | RDNT | Patel Mital EVP, Chief Operating Officer | 44,661 | $3.5M | Nov 11, 2026 | Nov 13, 2026 | |
| Exercise | IQV | Sherbet Eric See Remarks | 8,436 | $1.1M | Nov 9, 2026 | Nov 13, 2026 | |
| Sell | IQV | Sherbet Eric See Remarks | 4,446 | $1.2M | Nov 9, 2026 | Nov 13, 2026 | |
| Dispose | IQV | Sherbet Eric See Remarks | 3,990 | $1.1M | Nov 9, 2026 | Nov 13, 2026 | |
| Exercise | DGX | Plewman Patrick SVP for Diagnostic Services | 11,067 | $1.4M | Nov 9, 2026 | Nov 13, 2026 | |
| Sell | DGX | Plewman Patrick SVP for Diagnostic Services | 11,717 | $3.0M | Nov 9, 2026 | Nov 13, 2026 | |
| Sell | WRBY | Blumenthal Neil Harris Co-Chief Executive Officer, Director | 73,133 | $2.2M | Nov 9, 2026 | Nov 13, 2026 | |
| Sell | WRBY | Gilboa David Abraham Co-Chief Executive Officer, Director | 75,402 | $2.2M | Nov 9, 2026 | Nov 13, 2026 | |
| Exercise | TPR | Roe Scott A. CFO and COO | 93,875 | $3.4M | Nov 10, 2026 | Nov 13, 2026 | |
| Sell | TPR | Roe Scott A. CFO and COO | 54,644 | $7.4M | Nov 10, 2026 | Nov 13, 2026 | |
| Tax | TPR | Roe Scott A. CFO and COO | 63,231 | $8.6M | Nov 10, 2026 | Nov 13, 2026 | |
| Exercise | TPR | Crevoiserat Joanne C. Chief Executive Officer | 66,063 | $1.2M | Nov 11, 2026 | Nov 13, 2026 | |
| Sell | TPR | Crevoiserat Joanne C. Chief Executive Officer | 27,762 | $3.7M | Nov 11, 2026 | Nov 13, 2026 | |
| Tax | TPR | Crevoiserat Joanne C. Chief Executive Officer | 38,301 | $5.1M | Nov 11, 2026 | Nov 13, 2026 | |
| Sell | ROIV | Pulik Richard CFO | 300,000 | $12.5M | Nov 11, 2026 | Nov 13, 2026 | |
| Sell | ROIV | Venker Eric President & Immunovant CEO | 187,943 | $7.6M | Nov 10, 2026 | Nov 13, 2026 | |
| Sell | SNAP | Harris Ronan Chief Commercial Officer | 200,000 | $1.0M | Nov 12, 2026 | Nov 13, 2026 | |
| Sell | PVLA | Martini Jeffrey S Chief Scientific Officer | 12,500 | $2.1M | Nov 11, 2026 | Nov 12, 2026 | |
| Sell | CTEV | Klein Michael Stuart Director | 65,567 | $1.8M | Nov 12, 2026 | Nov 12, 2026 | |
| Sell | VRSN | Bidzos D James Exec. Chairman, Pres, & CEO, Director | 3,300 | $1.0M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | HNGE | Mecklenburg Gabriel M.I. Director, Exec. Chairman & Co-Founder | 200,000 | $24.5M | Nov 11, 2026 | Nov 12, 2026 | |
| Sell | HNGE | Budge James Chief Financial Officer | 35,907 | $4.4M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | CYRX | Hancock Daniel M Director | 74,379 | $1.5M | Nov 9, 2026 | Nov 12, 2026 | |
| Sell | HGTY | Hagerty Holding Corp. 10% owner | 11,500,000 | $164.8M | Nov 12, 2026 | Nov 12, 2026 | |
| Exercise | XNCR | Ranieri Richard J Director | 75,755 | $1.4M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | XNCR | Ranieri Richard J Director | 81,252 | $3.2M | Nov 10, 2026 | Nov 12, 2026 | |
| Exercise | GMED | Tobin James R Director | 41,666 | $2.3M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | GMED | Tobin James R Director | 41,666 | $3.1M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | MSFT | Numoto Takeshi EVP, Chief Marketing Officer | 5,000 | $2.7M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | GSAT | Clary Rebecca VP & Chief Financial Officer | 23,250 | $2.0M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | PACS | Jergensen Joshua President & COO | 40,000 | $2.0M | Nov 11, 2026 | Nov 12, 2026 | |
| Buy | JYNT | Jobson Charles E 10% owner | 236,116 | $1.6M | Nov 9, 2026 | Nov 12, 2026 | |
| Exercise | FWONA | Carey Chase Director | 574,331 | $16.1M | Nov 12, 2026 | Nov 12, 2026 | |
| Sell | FWONA | Carey Chase Director | 574,331 | $62.1M | Nov 12, 2026 | Nov 12, 2026 | |
| Exercise | AI | Siebel Thomas M CEO and Chairman of the Board, Director, 10% owner | 426,655 | $1.7M | Nov 11, 2026 | Nov 12, 2026 | |
| Sell | AI | Siebel Thomas M CEO and Chairman of the Board, Director, 10% owner | 426,655 | $5.1M | Nov 11, 2026 | Nov 12, 2026 | |
| Sell | MAR | Harrison Deborah Marriott Director, Member of 13(d) group | 11,985 | $5.0M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | ALL | Wilson Thomas J Chairman, President & CEO, Director | 130,917 | $34.0M | Nov 10, 2026 | Nov 12, 2026 | |
| Buy | OFIX | Juniper Investment Company, LLC 10% owner | 689,803 | $5.1M | Nov 11, 2026 | Nov 12, 2026 | |
| Exercise | DNTH | Savitz Ryan EVP, CFO & CBO | 124,042 | $2.5M | Nov 12, 2026 | Nov 12, 2026 | |
| Sell | DNTH | Savitz Ryan EVP, CFO & CBO | 124,042 | $11.2M | Nov 12, 2026 | Nov 12, 2026 | |
| Sell | PGNY | Anevski Peter CHIEF EXECUTIVE OFFICER, Director | 236,630 | $8.5M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | RYAN | Wuller Benjamin MIles CEO RSUM | 100,000 | $4.7M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | PGNY | Schlanger David J Executive Chairman, Director | 35,392 | $1.3M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | UHAL | Shoen Mark V 10% owner | 46,000 | $2.3M | Nov 10, 2026 | Nov 12, 2026 | |
| Tax | DGII | Konezny Ronald PRESIDENT AND CEO, Director | 29,019 | $1.9M | Nov 9, 2026 | Nov 12, 2026 | |
| Sell | LASR | Keeney Scott H President and CEO, Director | 200,000 | $8.4M | Nov 9, 2026 | Nov 12, 2026 | |
| Grant | WAFD | Beardall Brent J President & CEO, Director | 57,155 | $1.7M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | IRON | Savage William Jacob Chief Medical Officer | 16,035 | $1.4M | Nov 10, 2026 | Nov 12, 2026 | |
| Sell | CVNA | Quayle J Danforth Director | 27,655 | $2.0M | Nov 10, 2026 | Nov 12, 2026 |